花粉症市场报告：到 2030 年的趋势、预测和竞争分析

花粉症趋势和预测

预计到 2030 年，全球花粉症市场将达到 72 亿美元，2024 年至 2030 年复合年增长率为 4.5%。该市场的主要驱动力是过敏发生率的增加、过敏及其管理意识的提高以及持续的技术进步。全球花粉症市场的未来看起来充满希望，食品、吸入和药品市场充满机会。

• Lucintel 预测，由于皮质类固醇的功效、安全性和可用性，在预测期内将继续成为最大的领域。
• 在这个市场中，由于呼吸道过敏的高成长，吸入器仍将是最大的细分市场。
• 由于花粉症的高发生率和医疗基础设施未得到满足，预计亚太地区在预测期内将出现最高的增长。

花粉症市场的新趋势

花粉症市场观察到的一些主要趋势是由人口变化和技术进步（包括环境意识）所驱动的。

• 个人化过敏治疗：在过敏性疾病的治疗中，人们越来越注重根据每个人的基因体质和自然环境的特征进行个别化治疗。这改善了治疗结果和患者的生活品质。
• 数位健康整合：数位健康工具（包括行动应用程式和穿戴式装置）的兴起正在加强花粉症管理。这些技术有助于症状追踪、药物管理、即时花粉预测等。
• 扩大生技药品的使用：这类作用于过敏反应特定途径的药物的使用越来越多。这使得在治疗严重过敏患者时可以采取更好的选择性方法。
• 对环境影响的认识：提高对当前环境变化及其对花粉暴露程度影响的认识，有助于采取减少暴露程度和控制过敏反应症状的策略。
• 扩大免疫治疗选择：除了舌下免疫疗法和过敏原免疫疗法外，现在还有更多可供过敏患者使用的免疫疗法选择，提供了更可行的长期治疗选择。

这些变化正在透过更个人化、有效且易于使用的治疗方案重新调整花粉症市场。人们对改善患者治疗结果的管理策略的认识也不断提高和改进。

花粉症市场的最新趋势

花粉症市场的最新趋势是由有效治疗、个人化治疗、更好的诊断工具、改善的患者照护以及公众对解决全球花粉症日益流行的认识的提高所推动的，这反映了花粉症日益增长的趋势。

• 免疫疗法的进展：舌下免疫疗法和过敏原特异性免疫疗法的改进正在提供更好的长期治疗选择。这些创新提高了依从性并减少了过敏症状。
• 数位健康工具的普及：新的行动应用程式和穿戴式装置使得追踪花粉水平和管理症状成为可能。这些数位工具具有最新资料和个人化提案。
• 生技药品开发：针对过敏反应特定途径的新生技药品治疗为严重过敏患者提供了先进的选择。这些治疗方法正在演变成更好的治疗方法。
• 加强对环境因素的研究：气候变迁和环境污染对花粉水平影响的研究正在带来更好的过敏管理方法。它也对公共卫生政策和治疗方法影响。
• 过敏测试的增加：先进的过敏诊断和测试的可用性正在透过早期检测和个人化治疗计划、更好的过敏管理和减少过敏患者的痛苦来推动进步。

这些只是花粉症市场的变化，治疗方案的品质和有效性的整体提高补充了对个人化和有效的过敏管理日益增长的需求。

花粉症市场的策略性成长机会

从策略角度来看，花粉症市场提供了充足的成长机会。这种成长机会体现在以下领域：其中包括：应用主导、技术开拓、疾病意识的提高以及整体过敏性疾病管理解决方案的相关需求和要求。

• 免疫治疗服务的扩展：免疫治疗服务的开发和扩展，包括舌下服务和过敏原特异性治疗，增加了显着增长的潜力。先进的治疗方法因其长期有效性和其他相关益处而越来越受到患者的青睐，包括：
• 整合数位健康解决方案：投资数位健康解决方案，例如行动应用程式、监测过敏原暴露的微创穿戴装置以及远端监测患者身体参数，可以提高患者对健康和花粉症管理的参与度和即时资料。加强个人治疗计划的潜力。
• 生物疗法的成长：治疗严重过敏的生技药品的开发和商业化的成长代表着一个重大机会。这些治疗方法具有针对性，并且由于其有效性而越来越受到追捧。
• 宣传宣传活动：进行有关花粉症和可用治疗方法的宣传教育宣传活动将创造需求，从而推动公司的市场发展。提高公众意识将提高过敏管理解决方案的采用率。
• 渗透到新兴市场：印度和中国等新兴市场的过敏盛行率大幅上升，并具有巨大的成长潜力。透过围绕新兴市场的需求打造您的产品和服务，您可以接触到庞大且不断成长的基本客群。

花粉症市场的策略性成长机会带来了技术创新、治疗方法的扩大和患者照护的改善。能够利用这些机会的公司将能够在这个不断转型的市场中成功驾驭。

花粉症市场推广因素/问题

花粉症市场是由技术开拓、经济因素、监管问题以及挑战所驱动的。正确理解这些因素将有助于有效地驾驭市场。

推动花粉症市场的因素如下：

1.技术发展：技术发展：生技药品和数位健康解决方案等新的诊断和治疗方法正在推动市场成长。这将建立更好的方法和治疗方法来应对花粉症。

2.过敏发生率增加：全球花粉症的增加预计将增加对更好的治疗和管理的需求，从而扩大市场规模并增加对过敏研究的投资。

3.政府措施：透过政府特定补贴和公共卫生宣传活动对过敏领域的研究支持将有助于建立市场成长。改善过敏管理和治疗解决方案的政策影响市场动态。

4. 提高公众意识：提高对花粉症及其各种治疗方法的认识有助于接受过敏管理解决方案。公共教育可以提高公众意识。

5.透过扩大医疗保健的覆盖范围来渗透市场：根据健康需求，扩大医疗保健服务以及过敏治疗和管理的覆盖范围是市场的强大驱动因素，尤其是在快速增长的新兴市场。因此，有效的过敏管理解决方案正在变得可用。

花粉症市场面临的挑战如下。

1.治疗费用高昂：生技药品和免疫疗法等高度发达的过敏治疗方法的费用对一些患者来说是难以承受的。这对市场成长和渗透提出了挑战，特别是在低收入地区。

2. 监管障碍：新药和新技术面临严格的监管要求，延迟了市场进入并增加了开发成本。遵守这些法规是过敏市场营运公司面临的主要挑战之一。

3. 过敏反应的多样性：个别过敏反应的复杂性使得寻找通用方法变得困难。在这方面，变异性会影响治疗方法的有效性并影响市场的成长。

这些驱动因素和挑战是改变花粉症市场的相关力量，不仅影响新疗法的开拓，也影响市场动态和患者获得治疗的机会。解决这些因素将是企业在不断变化的市场环境中脱颖而出的关键因素。

花粉症依细分类别

本研究按治疗层级、产品类型、过敏原类型、最终用途和地区对全球花粉症进行预测。

各国花粉症市场前景

由于治疗方法的进步、环境条件的变化以及对过敏反应的意识提高，花粉症市场正在迅速发展。这些趋势反映了每个地区个人化和有效管理花粉症的更广泛趋势。

• 美国：近年来，美国增加了针对过敏的新治疗方法，例如 SLIT 和新生技药品，以帮助控制花粉症。公众意识的提高和新的数位健康工具也有助于控制过敏。
• 中国：先进的过敏测试和免疫治疗方案正在中国取得进展。盛行率的不断上升、政府对过敏研究和治疗的兴趣以及气候变迁导致都市区花粉排放量的增加正在推动该国市场的成长。
• 德国：透过个人化免疫疗法和改进的诊断工具，我们无疑处于推进过敏管理中精准医学的开发和应用的前沿。我们也认真对待环境政策，以减少花粉暴露并改善过敏管理。
• 印度：过敏治疗的意识正在增强。花粉症的蔓延和负担得起的治疗方法的可用性是市场成长的原因。该国也致力于提高公众的诊断能力和健康教育。
• 日本：日本市场越来越关注更复杂的过敏原特异性免疫疗法和滴鼻剂。最近，还整合了数位健康技术来帮助追踪和管理症状。随着研究和开发的进展，针对花粉症的治疗方法可能会出现。

常问问题

Q1.市场规模有多大？

答：到 2030 年，全球花粉症市场预计将达到 72 亿美元。

Q2.市场成长预测如何？

答：2024年至2030年，全球花粉症市场预计将以4.5%的复合年增长率成长。

Q3.影响市场成长的关键驱动因素有哪些？

答：这个市场的主要驱动力是过敏发生率的增加、过敏及其管理意识的提高以及持续的技术进步。

Q4.市场的主要细分市场是什么？

答：花粉症市场的未来充满希望，食品、吸入和药品市场都有机会。

Q5.市场上主要企业有哪些？

答：花粉症相关企业如下。

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Q6.未来最大的细分市场是什么？

答：Lucintel 预测，由于皮质类固醇的功效、安全性和可用性，在预测期内将继续成为最大的领域。

Q7. 未来五年预计哪个地区的市场最大？

答：由于花粉症的高发生率和医疗基础设施不发达，亚太地区预计在预测期内将出现最高的成长。

Q8. 可以客製化报告吗？

答：是的，Lucintel 列出了 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球花粉症市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球花粉症市场趋势（2018-2023）与预测（2024-2030）
• 按治疗层级的全球花粉症市场
  • 抗组织胺药
  • 减充血剂
  • 皮质类固醇
  • 肥大细胞稳定剂
  • 白三烯抑制剂
  • 鼻用抗胆碱能药物
  • 免疫调节剂
  • 自动注射肾上腺素
  • 免疫疗法
• 按产品类型分類的全球花粉症市场
  • 装置
  • 消耗品
  • 服务
• 按过敏原类型分類的全球花粉症市场
  • 食品
  • 吸入
  • 药品
  • 其他的
• 按最终用途分類的全球花粉症市场
  • 诊断实验室
  • 医院
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 按地区分類的全球花粉症市场
• 北美花粉症市场
• 欧洲花粉症市场
• 亚太花粉症市场
• 其他区域花粉症市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按治疗层级的全球花粉症市场成长机会
  • 按产品类型分類的全球花粉症市场成长机会
  • 按过敏原类型分類的全球花粉症市场成长机会
  • 全球花粉症市场成长机会（依最终用途）
  • 按地区分類的全球花粉症市场成长机会
• 全球花粉症市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球花粉症市场的产能
  • 全球花粉症市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Pollen Allergy Trends and Forecast

The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

• Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.
• Within this market, inhaled will remain the largest segment due to high growth of respiratory allergies.
• APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Emerging Trends in the Pollen Allergy Market

A few of the important trends observed in the pollen allergy market are driven by changes in demography and technological advancement-including environmental awareness.

• Personalized Allergy Treatments: Increasingly, there is focus on personalized medicine in the treatment of allergic conditions based on the specific characteristics of each individual's genetic makeup and natural environmental exposure. This is improving treatment outcomes and the quality of patients' lives.
• Digital Health Integration: The rise of digital health tools, including mobile apps and wearable devices, is enhancing pollen allergy management. These technologies help track symptoms, manage medications, and provide real-time pollen forecasts.
• Greater Use of Biologics: There is greater use of drugs in this class, as they act on specific pathways in the allergic response. This allows for better and more selective approaches to the treatment of individuals with severe allergies.
• Awareness of the Impact of the Environment: There is increased awareness regarding the current changes in the environment and their consequences for the levels of exposure to pollen, encouraging strategies for reducing the level of exposure and managing the symptoms of allergic reactions.
• Expanding the Basket of Immunotherapy Options: Besides sublingual and allergen immunotherapies, a widening array of immunotherapies is now available for allergy sufferers, affording more viable long-term treatment options and thus yielding better patient outcomes that give more momentum to the growth of the market.

These changes are reconditioning the pollen allergy market with more personalized, effective, and accessible treatment options. They are increasing awareness and improvements in management strategies to achieve better patient outcomes.

Recent Developments in the Pollen Allergy Market

The recent developments in pollen allergy markets reflect the growing trend toward effective treatment, treatment personalization, better diagnostic tools, and heightened mass awareness in order to improve patient care and tackle the growing prevalence of pollen allergy worldwide.

• Advancement in Immunotherapy: Improvement in sublingual and allergen-specific immunotherapies is offering superior long-term treatment options. These technological innovations are leading to increased compliance and reducing the intensity of allergy symptoms.
• Increased Adoption of Digital Health Tools: New mobile applications and wearable devices have allowed tracking of pollen levels along with the management of symptoms. These digital tools provide current data and personalized suggestions.
• Development of Biologic Drugs: New biologic treatments targeting specific pathways in allergic reactions are offering advanced options for patients with severe allergies. These drugs are leading to better and improved ways of treatment.
• Increased Research on Environmental Factors: Research on climate change and environmental pollution effects on pollen amounts is leading to better allergy management approaches. It is also influencing public health policies and modes of treatment.
• Increased Allergy Testing: Advanced diagnostics and availability of testing for allergies spur development through early detection and personalized treatment plans, better allergy management, and alleviating the sufferings of allergic people.

These are indeed changes in the face of the pollen allergy market, where overall improvement in the quality and effectiveness of the treatment options compensates for the growing need for personalized and effective allergy management.

Strategic Growth Opportunities for Pollen Allergy Market

The market for pollen allergies has provided ample opportunities for growth from a strategic standpoint, as this can be reflected in the following areas: application-driven, technological developments, an increase in awareness toward the disease, and associated needs or demand for overall management solutions of the allergic condition.

• Expanding Immunotherapy Services: Developing and expanding immunotherapy services, including sublingual services and allergen-specific therapies, increases significant growth potential. Advanced treatments, which are being increasingly patronized by patients due to their long-term effectiveness and other associated benefits, include:.
• Digital Health Solution Integration: Investment in digital health solutions, such as mobile apps, wearable devices that are minimally invasive for monitoring allergen exposure, and remote monitoring of the patients' body parameters-huge potential to enhance engagement of patients in their health and pollen allergy management, in real-time data, and treatment planning on a personal basis.
• Growth in Biologic Treatments: Growth in the development and commercialization of biologic drugs for severe allergies is at a critical opportunity. These treatments are targeted and are sought after increasingly due to their efficiency.
• Awareness Campaigns: By launching the sensitization educational campaigns on pollen allergy and treatments available, demand will be created and thereby drive the market for the company. Increased public awareness will result in the adoption of high rates of solutions for the management of allergies.
• Emerging Market Penetration: Emerging markets like India and China, depicting a high rise in prevalence due to allergies, will provide a huge growth potential. Molding products and services in line with the requirements of the emerging markets will capture a large and growing customer base.

The strategic opportunities for growth in the pollen allergy market brought innovation, expansion to the treatments, and improved patient care. Companies able to capitalize on opportunities are well diluted to navigate the market as it continues to transform.

Pollen Allergy Market Driver and Challenges

The pollen allergy market is driven as well as challenged by technological developments, economic factors, and regulatory concerns. Proper insight into the factors will help one wade through the market effectively.

The factors responsible for driving the pollen allergy market include:

1. Technological Developments: New diagnosis and treatment methods such as biologics and digital health solutions are driving growth in the market. This sets a better approach to dealing with pollen allergies and treated ways.

2. Increased Incidence of Allergies: Due to global increase in pollen allergies, the demand for better treatment and management is likely to rise, which in turn shall increase the market size and investment in allergy research.

3. Government Initiatives: Support for research in the domain of allergies through subsidies by the government and public health campaigns help to establish market growth. The policies to improve allergy management and solutions in treatment influence market dynamics.

4. Increasing Public Awareness: Increasing awareness on pollen allergy and its various methods of treatment is aiding in the acceptance of solutions for the management of allergies. Public education has made increasing public awareness possible.

5. Market Penetration due to Expansion of Healthcare Access: In line with the health needs, access and expansion into healthcare services and treatment or management of allergies, particularly in the fast-growing or emerging markets, are poised as strong drivers of the market. This, in turn, is making available efficient solutions for allergy management.

Challenges in the pollen allergy market are:

1. High Treatment Costs: The cost of highly developed allergy treatment, like biologics and immunotherapy, is unaffordable to some patients. This acts as a challenge to the growth and adoption in the market, especially in lower-income regions.

2. Regulatory Hurdles: New drugs and technology face strict regulatory requirements, which delay entry into the market and translate into growing development costs. Following such regulations is one of the key challenges the companies working in the allergy market face.

3. Variability of Allergic Reactions: It is the sophistication of the individual allergic reaction that has made the search for a common approach difficult. In this regard, variability influences how treatments can be effective; thus, it affects the growth of the market.

These drivers and challenges are pertinent forces changing the pollen allergy market, which not only determines new treatment developments but also the market dynamics and accessibility of care to patients. Working on these elements will be a key factor in the emergence of enterprises in the changing market scenario.

List of Pollen Allergy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Pollen Allergy by Segment

The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.

Pollen Allergy Market by Therapeutics Drug Class [Analysis by Value from 2018 to 2030]:

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anticholinergics
• Immunomodulators
• Auto injectable Epinephrine
• Immunotherapy

Pollen Allergy Market by Product Type [Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

Pollen Allergy Market by Allergen Type [Analysis by Value from 2018 to 2030]:

• Food
• Inhaled
• Drug
• Others

Pollen Allergy Market by End Use [Analysis by Value from 2018 to 2030]:

• Diagnostic Laboratories
• Hospitals
• Others

Pollen Allergy Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Pollen Allergy Market

The pollen allergy market is evolving rapidly due to advancements in treatments, changing environmental conditions, and increased awareness of allergic reactions. These developments reflect a broader trend toward personalized and effective management of pollen allergies across different regions.

• United States: Over the past few years, new treatments for allergies, such as SLIT and new biologic medications, have grown in the U.S., which has helped the management of pollen allergy. More awareness among the general public and new digital health tools also help in the management of the allergy.
• China: In China, there is growing infiltration by advanced allergy testing and immunotherapy options. Increasing prevalence, government interest in allergy research and treatment, along with high pollen counts in urban areas because of climate change, is driving market growth in the country.
• Germany is no doubt at the front line in advancing the development and application of precision medicine in managing allergies through personalized immunotherapy and improved diagnostic tools. It also dedicates some seriousness to the environmental policies it creates with a view to reduced pollen exposure and improving allergy management at large.
• India: With availability, the awareness about allergy treatments is increasing. Greater pollen allergies and availability of treatments at reasonable prices are the reasons for the market's growth. Besides, the country is putting emphasis on diagnostic capability building and health education of the general public.
• Japan: Japanese markets are increasingly focusing on more sophisticated allergen-specific immunotherapy and nasal sprays. In recent times, they have also integrated digital health technologies that help track symptoms and manage them. With increased research and development, the treatments are going to be more specific in the case of pollen allergies.

Features of the Global Pollen Allergy Market

Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).

Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the pollen allergy market size?

Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.

Q2. What is the growth forecast for pollen allergy market?

Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pollen allergy market?

Answer: The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

Q4. What are the major segments for pollen allergy market?

Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key pollen allergy market companies?

Answer: Some of the key pollen allergy companies are as follows:

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Q6. Which pollen allergy market segment will be the largest in future?

Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.

Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Pollen Allergy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Pollen Allergy Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Pollen Allergy Market by Therapeutics Drug Class
  • 3.3.1: Antihistamines
  • 3.3.2: Decongestants
  • 3.3.3: Corticosteroids
  • 3.3.4: Mast Cell Stabilizers
  • 3.3.5: Leukotriene Inhibitors
  • 3.3.6: Nasal Anticholinergics
  • 3.3.7: Immunomodulators
  • 3.3.8: Auto injectable Epinephrine
  • 3.3.9: Immunotherapy
• 3.4: Global Pollen Allergy Market by Product Type
  • 3.4.1: Instruments
  • 3.4.2: Consumables
  • 3.4.3: Services
• 3.5: Global Pollen Allergy Market by Allergen Type
  • 3.5.1: Food
  • 3.5.2: Inhaled
  • 3.5.3: Drug
  • 3.5.4: Others
• 3.6: Global Pollen Allergy Market by End Use
  • 3.6.1: Diagnostic Laboratories
  • 3.6.2: Hospitals
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Pollen Allergy Market by Region
• 4.2: North American Pollen Allergy Market
  • 4.2.1: North American Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.2.2: North American Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.3: European Pollen Allergy Market
  • 4.3.1: European Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.3.2: European Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.4: APAC Pollen Allergy Market
  • 4.4.1: APAC Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.4.2: APAC Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.5: ROW Pollen Allergy Market
  • 4.5.1: ROW Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.5.2: ROW Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pollen Allergy Market by Therapeutics Drug Class
  • 6.1.2: Growth Opportunities for the Global Pollen Allergy Market by Product Type
  • 6.1.3: Growth Opportunities for the Global Pollen Allergy Market by Allergen Type
  • 6.1.4: Growth Opportunities for the Global Pollen Allergy Market by End Use
  • 6.1.5: Growth Opportunities for the Global Pollen Allergy Market by Region
• 6.2: Emerging Trends in the Global Pollen Allergy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pollen Allergy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pollen Allergy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: ALK-Abello
• 7.2: Circassia
• 7.3: DBV Technologies
• 7.4: Genentech
• 7.5: GlaxoSmithKline
• 7.6: HAL Allergy
• 7.7: Johnson & Johnson
• 7.8: Meda AB
• 7.9: Merck & Co
• 7.10: Mylan